IP Library Granted Patent US 7,229,436
Granted Patent B2
US 7,229,436 · App. 10/400,187 · Granted Jun 12, 2007

Method and kit for treatment of tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,229,436
App. No.
10/400,187
Granted
Jun 12, 2007
Kind
B2
Abstract

These and other objects of the present invention are achieved in a method for creating a desired tissue effect. An RF electrode is provided that includes a conductive portion. The RF electrode is coupled to a fluid delivery member that delivers a cooling fluidic medium to a back surface of the RF electrode. A dielectric is positioned on a skin surface. The RF electrode is coupled with the dielectric. RF energy is delivered from the RF electrode and the dielectric to the skin surface.

Claims (50)

1. A method for creating a desired tissue effect with an RF electrode having a back surface and coupled on a dielectric material, comprising:

cooling the back surface of the RF electrode;

positioning the dielectric material on an external skin surface of a body; and

delivering RF energy from the RF electrode by capacitive coupling through the dielectric material and into the skin surface, the cooling and delivering being controlled so as to create a reverse thermal gradient whereby a temperature of the external skin surface is lower than a temperature of underlying tissue.

2. The method of claim 1 , wherein cooling the back surface of the RF electrode is accomplished using a thermo-electric cooler.

3. The method of claim 1 , further comprising:

introducing a conductive media between the RF electrode and the dielectric.

4. The method of claim 1 , wherein the RF electrode is coupled to a support structure, the support structure including a back plane coupled to a plurality of electrical contact pads.

5. The method of claim 1 , wherein the RF energy is delivered to tissue underlying the external skin surface without creating substantial necrosis at the skin surface.

6. The method of claim 1 , wherein cooling the back surface of the RF electrode further comprises:

delivering a controllable amount of a cooling fluidic medium to the back surface of the RF electrode.

7. The method of claim 1 , wherein cooling the back surface of the RF electrode further comprises:

providing an atomizing delivery of a cooling fluidic medium to the back surface of the RF electrode.

8. The method of claim 1 , wherein cooling the back surface of the RF electrode further comprises:

evaporatively cooling the back surface of the RF electrode and conductively cooling the external skin surface in contact with the dielectric material.

9. The method of claim 1 , wherein cooling the back surface of the RF electrode further comprises:

delivering a cooling fluidic medium to the back surface of the RF electrode at substantially any orientation of a front surface of the RF electrode relative to a direction of gravity.

10. The method of claim 1 , wherein the desired tissue effect is selected from dermal remodeling and tightening, wrinkle reduction, elastosis reduction, scar reduction, sebaceous gland removal, sebaceous deactivation, hair follicle removal, adipose tissue remodeling or removal, spider vein removal, modification of contour irregularities of a skin surface, creation scar or nascent collagen, reduction of bacteria activity of skin, reduction of skin pore size, and unclogging skin pores.

11. The method of claim 1 , wherein a temperature of the external skin surface is lower than an underlying collagen containing tissue site.

12. The method of claim 1 , wherein RF energy is delivered through the external skin surface to underlying tissue for a sufficient time to induce a change in collagen tissue in the underlying tissue while minimizing cellular necrosis of the external skin surface to create the desired tissue effect.

13. The method of claim 1 , wherein the RF electrode includes a metal conductive portion.

14. The method of claim 1 , further comprising:

a first sensor coupled to the RF electrode.

15. The method of claim 14 , further comprising:

sensing at least one of a temperature of the back surface of the RF electrode or a temperature of the external skin surface.

16. The method of claim 1 , wherein the RF electrode is coupled to a non-volatile memory.

17. A method for creating a desired tissue effect with an RF electrode having a back surface and coupled on a dielectric material, comprising:

cooling the back surface of the RF electrode;

positioning the dielectric material on an external skin surface of a body;

delivering RF energy from the RF electrode by capacitive coupling through the dielectric material and into the skin surface; and

creating a reverse thermal gradient on at least a portion of the skin surface, the reverse thermal gradient cooling the skin surface while heating underlying tissue, wherein a temperature of the skin surface is lower than a temperature of the underlying tissue.

18. The method of claim 17 , wherein cooling the back surface of the RF electrode is accomplished using a thermo-electric cooler.

19. The method of claim 17 , wherein the RF electrode is coupled to a support structure, the support structure including a back plane coupled to a plurality of electrical contact pads.

20. The method of claim 17 , wherein the RF energy is delivered to tissue underlying the skin surface without creating substantial necrosis at the skin surface.

21. The method of claim 17 , wherein cooling the back surface of the RF electrode further comprises:

delivering a controllable amount of a cooling fluidic medium to the back surface of the RF electrode.

22. The method of claim 17 , wherein cooling the back surface of the RF electrode further comprises:

providing an atomizing delivery of a cooling fluidic medium to the back surface of the RF electrode.

23. The method of claim 17 , wherein cooling the back surface of the RF electrode further comprises:

evaporatively cooling the back surface of the RF electrode and conductively cooling the skin surface in contact with the dielectric material.

24. The method of claim 17 , wherein cooling the back surface of the RF electrode further comprises:

delivering a cooling fluidic medium to the back surface of the RF electrode at substantially any orientation of a front surface of the RF electrode relative to a direction of gravity.

25. The method of claim 17 , wherein the desired tissue effect is selected from dermal remodeling and tightening, wrinkle reduction, elastosis reduction, scar reduction, sebaceous gland removal, sebaceous deactivation, hair follicle removal, adipose tissue remodeling or removal, spider vein removal, modification of contour iffegularities of a skin surface, creation scar or nascent collagen, reduction of bacteria activity of skin, reduction of skin pore size, and unclogging skin pores.

26. The method of claim 17 , wherein a temperature of the skin surface is lower than an underlying collagen containing tissue site.

27. The method of claim 17 , wherein RF energy is delivered through the skin surface to underlying tissue for a sufficient time to induce a change in collagen tissue in the underlying tissue while minimizing cellular necrosis of the skin surface to create the desired tissue effect.

28. The method of claim 17 , wherein the RF electrode includes a metal conductive portion.

29. The method of claim 17 , further comprising:

a first sensor coupled to the RF electrode.

30. The method of claim 29 , further comprising:

sensing at least one of a temperature of the back surface of the RF electrode or a temperature of the skin surface.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
SECURITY INTEREST Recorded Jul 18, 2016
From: SOLTA MEDICAL, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039178/0970 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: SOLTA MEDICAL, INC.
Reel/Frame 032126/0206 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: SILICON VALLEY BANK
To: SOLTA MEDICAL, INC.
Reel/Frame 032126/0475 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 19, 2013
From: SOLTA MEDICAL, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031674/0546 →
SECURITY INTEREST - MEZZANINE LOAN Recorded Apr 24, 2013
From: SOLTA MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 030281/0524 →
SECURITY AGREEMENT Recorded Jun 16, 2009
From: SOLTA MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 022824/0837 →
RELEASE OF SECURITY INTEREST Recorded Mar 9, 2009
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: SOLTA MEDICAL, INC. ( F/K/A/ THERMAGE, INC.)
Reel/Frame 022354/0737 →
SECURITY AGREEMENT Recorded Dec 9, 2005
From: THERMAGE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 016871/0391 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2005
From: STERN, ROGER A; LEVINSON, MITCHELL; WEBER, BRYAN
To: THERMAGE, INC.
Reel/Frame 016661/0045 →